Finanzwire Finanzwire
Basculer en Français
10767 Companies
231815 Keywords
160272 Articles
123348 Press releases
Headlines Articles Press releases Relief Therapeutics Holding SA Remove
  1. Home
  2. Companies
  3. Relief Therapeutics Holding SA
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 10/04/2024 at 07:05, 1 year 9 months ago

    Relief Therapeutics Reports Positive Study Results for Phenylketonuria Treatment

    Relief Therapeutics RLF-OD032 Phenylketonuria Sapropterin Dihydrochloride Clinical Study Results
  • PRESS RELEASE

    published on 10/04/2024 at 07:00, 1 year 9 months ago

    Relief Therapeutics Reports Positive Results from RLF-OD032 Proof-of-Concept Clinical Study for Phenylketonuria

    Relief Therapeutics reports positive results from RLF-OD032 proof-of-concept clinical study for Phenylketonuria, showing bioequivalence with KUVAN(R) in managing PKU. RLF-OD032 aims to offer a patient-friendly, portable solution for PKU treatment
    Clinical Study Relief Therapeutics RLF-OD032 Bioéquivalence Phenylketonuria
    Logo of Relief Therapeutics Holding SA
  • BRIEF

    published on 09/23/2024 at 07:05, 1 year 10 months ago

    Relief Therapeutics Announces $2 Million Milestone Under Royalty Sales Agreement

    FDA Approval Relief Therapeutics Milestone Payment Niemann-Pick Disease SWK Funding
  • PRESS RELEASE

    published on 09/23/2024 at 07:00, 1 year 10 months ago

    Relief Therapeutics Announces $2 Million Milestone Under Royalty Sales Agreement

    Relief Therapeutics announced $2 million milestone payment under royalty sales agreement after FDA approval of arimoclomol for Niemann-Pick Disease Type C treatment
    FDA Approval Relief Therapeutics Milestone Payment Arimoclomol Royalty Sales Agreement
    Logo of Relief Therapeutics Holding SA
Previous page
1 ... 8 9
Accesswire
  • Published on 07/25/2026 at 00:35, 1 day 19 hours ago

    Pathfinder Ventures Inc. Provides Corporate Update

  • Published on 07/24/2026 at 23:00, 1 day 20 hours ago

    NV Gold Announces Closing of Non-Brokered Private Placement

  • Published on 07/24/2026 at 22:15, 1 day 21 hours ago

    Gold Terra Announces Closing of First Tranche of C$10.8M LIFE Offering With Strong Participation From Strategic Shareholder David Harquail

  • Published on 07/24/2026 at 22:05, 1 day 21 hours ago

    Findev Inc. Announces CCAA Proceedings Involving 1682 Victoria Park Avenue Inc. and Related Party Subordination Arrangement

  • Published on 07/24/2026 at 20:00, 1 day 23 hours ago

    Unusual Machines to Announce Second Quarter 2026 Financial Results and Provide Corporate Update

View all ACCESSWIRE
EQS Group
  • Published on 07/26/2026 at 19:12, 36 minutes ago

    EQS-Adhoc: Kapsch TrafficCom reaches agreement with its major financial creditors on key terms of a restructuring.

  • Published on 07/26/2026 at 18:46, 1 hour 2 minutes ago

    EQS-Adhoc: Kapsch TrafficCom reaches agreement with its major financial creditors on key terms of a restructuring.

  • Published on 07/24/2026 at 19:06, 2 days ago

    End of Stabilisation Notice

  • Published on 07/24/2026 at 19:04, 2 days ago

    Stabilisation Notice

  • Published on 07/24/2026 at 18:44, 2 days 1 hour ago

    Fuller, Smith & Turner PLC: Transaction in own shares

View all EQS
Les Echos
  • Published on 07/24/2026 at 18:50, 2 days ago

    Disclosure of transactions in own shares from July 20 to July 24, 2026

  • Published on 07/24/2026 at 18:11, 2 days 1 hour ago

    H1 2026 liquidity contract statement for TF1

  • Published on 07/24/2026 at 18:06, 2 days 1 hour ago

    TF1 First-Half 2026 Financial Report

  • Published on 07/24/2026 at 18:00, 2 days 1 hour ago

    TF1 H1 2026 results - Press release

  • Published on 07/24/2026 at 08:00, 2 days 11 hours ago

    Accor signs a definitive binding agreement on the sale of its stake in Essendi

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy